Literature DB >> 12563659

The determinants of health care expenditure: testing pooling restrictions in small samples.

Helmut Herwartz1, Bernd Theilen.   

Abstract

Health care expenditure has increased substantially in all Western industrialized countries in the last decades. The necessity to contain the increase in health care expenditure has motivated the analysis of its determinants to explain differences across countries and health systems. However, recent studies have questioned the use of cross section data arguing that health systems are too different to allow for such comparisons. In this paper we investigate whether this criticism is really justified. We analyze the variations of health care expenditure in OECD countries relative to income, population aging and technological change. Our analysis is based on pooled cross section data and time series. Firstly, formulating error correction models for individual countries we demonstrate that in almost all cases the investigated variables are cointegrated. Secondly, we use a bootstrap framework for inference and examine whether the influence of explanatory variables is unique across countries. Applying recursive estimation procedures we find evidence for cross country homogeneity during the period 1961-1979. In the last two decades health care dynamics become more and more country specific thus indicating divergence of health systems and the growing importance of country-specific effects in the explanation of differences in health care expenditure. Copyright 2002 John Wiley & Sons, Ltd.

Mesh:

Year:  2003        PMID: 12563659     DOI: 10.1002/hec.700

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  12 in total

1.  The income elasticity of health care spending in developing and developed countries.

Authors:  Marwa Farag; A K NandaKumar; Stanley Wallack; Dominic Hodgkin; Gary Gaumer; Can Erbil
Journal:  Int J Health Care Finance Econ       Date:  2012-03-15

2.  Is health care a luxury? New evidence from OECD data.

Authors:  Anindya Sen
Journal:  Int J Health Care Finance Econ       Date:  2005-06

3.  Determinants of health expenditure growth of the OECD countries: jackknife resampling plan estimates.

Authors:  Albert A Okunade; Mustafa C Karakus; Charles Okeke
Journal:  Health Care Manag Sci       Date:  2004-08

4.  Labelled drug-related public expenditure in relation to gross domestic product (GDP) in Europe: a luxury good?

Authors:  Luis Prieto
Journal:  Subst Abuse Treat Prev Policy       Date:  2010-05-17

5.  Do political factors influence public health expenditures? Evidence pre- and post-great recession.

Authors:  Héctor Bellido; Lorena Olmos; Juan Antonio Román-Aso
Journal:  Eur J Health Econ       Date:  2018-10-24

6.  Is health care a luxury or a necessity or both? Evidence from Turkey.

Authors:  Nilgun Cil Yavuz; Veli Yilanci; Zehra Ayca Ozturk
Journal:  Eur J Health Econ       Date:  2011-07-28

7.  How relevant is environmental quality to per capita health expenditures? Empirical evidence from panel of developing countries.

Authors:  Adamu Yahaya; Norashidah Mohamed Nor; Muzafar Shah Habibullah; Judhiana Abd Ghani; Zaleha Mohd Noor
Journal:  Springerplus       Date:  2016-06-29

8.  Identification of Health Expenditures Determinants: A Model to Manage the Economic Burden of Cardiovascular Disease.

Authors:  Fiorella Pia Salvatore; Alessia Spada; Francesca Fortunato; Demetris Vrontis; Mariantonietta Fiore
Journal:  Int J Environ Res Public Health       Date:  2021-04-27       Impact factor: 3.390

9.  Prevalence of visual impairment in relation to the number of ophthalmologists in a given area: a nationwide approach.

Authors:  Antoine J Lafuma; Antoine P Brézin; Francis L Fagnani; Mounir Mesbah; Gilles H Berdeaux
Journal:  Health Qual Life Outcomes       Date:  2006-06-06       Impact factor: 3.186

10.  Impact of population ageing on the costs of hospitalisations for cardiovascular disease: a population-based data linkage study.

Authors:  Ninh Thi Ha; Delia Hendrie; Rachael Moorin
Journal:  BMC Health Serv Res       Date:  2014-11-13       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.